209 related articles for article (PubMed ID: 11714112)
1. Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States).
Hatch EE; Herbst AL; Hoover RN; Noller KL; Adam E; Kaufman RH; Palmer JR; Titus-Ernstoff L; Hyer M; Hartge P; Robboy SJ
Cancer Causes Control; 2001 Nov; 12(9):837-45. PubMed ID: 11714112
[TBL] [Abstract][Full Text] [Related]
2. Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract.
Troisi R; Hatch EE; Palmer JR; Titus L; Robboy SJ; Strohsnitter WC; Herbst AL; Adam E; Hyer M; Hoover RN
Am J Obstet Gynecol; 2016 Sep; 215(3):322.e1-8. PubMed ID: 26979629
[TBL] [Abstract][Full Text] [Related]
3. Incidence of squamous neoplasia of the cervix and vagina in des-exposed daughters.
Hatch E; Herbst A; Hoover R; Noller K; Adam E; Kaufman R; Palmer J; Titus-Ernstoff L; Hyer M; Robboy S
Ann Epidemiol; 2000 Oct; 10(7):467. PubMed ID: 11018391
[TBL] [Abstract][Full Text] [Related]
4. In utero exposure to DES. Evaluation and followup of 199 women.
Fowler WC; Edelman DA
Obstet Gynecol; 1978 Apr; 51(4):459-63. PubMed ID: 662229
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol.
Camp EA; Prehn AW; Shen J; Herbst AL; Strohsnitter WC; Hobday CD; Robboy SJ; Adam E
J Womens Health (Larchmt); 2015 Apr; 24(4):308-15. PubMed ID: 25768943
[TBL] [Abstract][Full Text] [Related]
6. Development of cervical and vaginal squamous cell neoplasia as a late consequence of in utero exposure to diethylstilbestrol.
Bornstein J; Adam E; Adler-Storthz K; Kaufman RH
Obstet Gynecol Surv; 1988 Jan; 43(1):15-21. PubMed ID: 2829071
[TBL] [Abstract][Full Text] [Related]
7. Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix.
Herbst AL; Cole P; Colton T; Robboy SJ; Scully RE
Am J Obstet Gynecol; 1977 May; 128(1):43-50. PubMed ID: 851158
[TBL] [Abstract][Full Text] [Related]
8. Role of hormones including diethylstibestrol (DES) in the pathogenesis of cervical and vaginal intraepithelial neoplasia.
Robboy SJ; Truslow GY; Anton J; Richart RM
Gynecol Oncol; 1981 Oct; 12(2 Pt 2):S98-110. PubMed ID: 7030882
[TBL] [Abstract][Full Text] [Related]
9. Dysplasia and cytologic findings in 4,589 young women enrolled in diethylstilbestrol-adenosis (DESAD) project.
Robboy SJ; Szyfelbein WM; Goellner JR; Kaufman RH; Taft PD; Richard RM; Gaffey TA; Prat J; Virata R; Hatab PA; McGorray SP; Noller KL; Townsend D; Labarthe D; Barnes AB
Am J Obstet Gynecol; 1981 Jul; 140(5):579-86. PubMed ID: 7195652
[TBL] [Abstract][Full Text] [Related]
10. Cancer risk in women exposed to diethylstilbestrol in utero.
Hatch EE; Palmer JR; Titus-Ernstoff L; Noller KL; Kaufman RH; Mittendorf R; Robboy SJ; Hyer M; Cowan CM; Adam E; Colton T; Hartge P; Hoover RN
JAMA; 1998 Aug; 280(7):630-4. PubMed ID: 9718055
[TBL] [Abstract][Full Text] [Related]
11. Squamous neoplasia in DES-exposed women.
Stafl A
Obstet Gynecol Surv; 1979 Nov; 34(11):847. PubMed ID: 523033
[TBL] [Abstract][Full Text] [Related]
12. DES daughters in France: experts' points of view on the various genital, uterine and obstetric pathologies, and in utero DES exposure.
Clement R; Guilbaud E; Barrios L; Rougé-Maillart C; Jousset N; Rodat O
Med Sci Law; 2014 Oct; 54(4):219-29. PubMed ID: 24534146
[TBL] [Abstract][Full Text] [Related]
13. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
[TBL] [Abstract][Full Text] [Related]
14. The current status of the DES-exposed population.
Herbst AL
Obstet Gynecol Annu; 1981; 10():267-78. PubMed ID: 7024873
[TBL] [Abstract][Full Text] [Related]
15. Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up.
Huo D; Anderson D; Palmer JR; Herbst AL
Gynecol Oncol; 2017 Sep; 146(3):566-571. PubMed ID: 28689666
[TBL] [Abstract][Full Text] [Related]
16. Cancer risk in women prenatally exposed to diethylstilbestrol.
Troisi R; Hatch EE; Titus-Ernstoff L; Hyer M; Palmer JR; Robboy SJ; Strohsnitter WC; Kaufman R; Herbst AL; Hoover RN
Int J Cancer; 2007 Jul; 121(2):356-60. PubMed ID: 17390375
[TBL] [Abstract][Full Text] [Related]
17. Management of the adolescent girl exposed in utero to DES.
Gerbie MV
Pediatr Ann; 1981 Dec; 10(12):23-6. PubMed ID: 7335401
[TBL] [Abstract][Full Text] [Related]
18. Risk of breast cancer in women exposed to diethylstilbestrol in utero: prelimiinary results (United States).
Palmer JR; Hatch EE; Rosenberg CL; Hartge P; Kaufman RH; Titus-Ernstoff L; Noller KL; Herbst AL; Rao RS; Troisi R; Colton T; Hoover RN
Cancer Causes Control; 2002 Oct; 13(8):753-8. PubMed ID: 12420954
[TBL] [Abstract][Full Text] [Related]
19. Congenital diethylstilbestrol-associated vaginal/cervical adenosis (DES babies).
Barclay DL
J Ark Med Soc; 1979 May; 75(12):451-2. PubMed ID: 156173
[TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinoma in situ of the vagina and cervix after intrauterine DES exposure.
Veridiano NP; Tancer ML; Weiner EA
Obstet Gynecol; 1978 Jul; 52(1 Suppl):30S-33S. PubMed ID: 683639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
